Matt Wade
Matt supports the Biopharma Journal Finance editorial team with reporting, research, and audience development. He was previously with WallStreet International in NYC.
Recent Post
Viking Therapeutics stock (VKTX) could hit all time high and here’s...
Viking Therapeutics, Inc. (VKTX), a clinical-stage biopharmaceutical company, is making significant strides in its pipeline of treatments for obesity, liver diseases, and...
